PRIMARY GLIOBLASTOMA
Clinical trials for PRIMARY GLIOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new PRIMARY GLIOBLASTOMA trials appear
Sign up with your email to follow new studies for PRIMARY GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a new biologic boost standard brain cancer therapy?
Disease control OngoingThis trial is testing whether adding an experimental drug called XS005 to the standard chemotherapy regimen (Stupp) is safe and shows promise for people with glioblastoma, an aggressive brain tumor. The study involves 13 adults aged 18 to 70 who will receive XS005 infusions over …
Matched conditions: PRIMARY GLIOBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: Dushu Lake Hospital Affiliated to Soochow University • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New light therapy targets deadly brain tumors during surgery
Disease control OngoingThis study tests a treatment called photodynamic therapy (PDT) for people with a severe brain cancer called glioblastoma. Patients take a drug that makes cancer cells sensitive to light, then during surgery, a special light is used to destroy remaining tumor cells. The goal is to…
Matched conditions: PRIMARY GLIOBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: Hemerion Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New drug combo shows promise in aggressive brain cancer trial
Disease control OngoingThis study tests whether adding the experimental drug LAM561 to standard radiation and chemotherapy can help people with newly diagnosed glioblastoma, a fast-growing brain tumor. About 144 adults aged 18 to 75 will receive either LAM561 or a placebo alongside their usual treatmen…
Matched conditions: PRIMARY GLIOBLASTOMA
Phase: PHASE2, PHASE3 • Sponsor: Laminar Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC